CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration The Prognostic Significance of Periprocedural Infarction in the Era of Potent Antithrombotic Therapy: The PRAGUE-18 Substudy Prevalence and Prognosis of Unrecognized Myocardial Infarction Determined by Cardiac Magnetic Resonance in Older Adults A Novel Circulating MicroRNA for the Detection of Acute Myocarditis Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial Association of Silent Myocardial Infarction and Sudden Cardiac Death Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock Impact of Chronic Total Coronary Occlusion Location on Long-term Survival After Percutaneous Coronary Intervention

Original ResearchVolume 74, Issue 4, July 2019

JOURNAL:J Am Coll Cardiol. Article Link

Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction

R Twerenbold, JP Costabel, T Nestelberger et al. Keywords: 0/1-h algorithm; acute myocardial infarction; high-sensitivity cardiac troponin; outcome; rule-out; safety

ABSTRACT


BACKGROUND - The European Society of Cardiology (ESC) recommends the 0/1-h algorithm for rapid triage of patients with suspected nonST-segment elevation myocardial infarction (MI). However, its impact on patient management and safety when routinely applied is unknown.

 

OBJECTIVES - This study sought to determine these important real-world outcome data.

 

METHODS - In a prospective international study enrolling patients presenting with acute chest discomfort to the emergency department (ED), the authors assessed the real-world performance of the ESC 0/1-h algorithm using high-sensitivity cardiac troponin T embedded in routine clinical care and its associated 30-day rates of major adverse cardiac events (MACE) (the composite of cardiovascular death and MI).

 

RESULTS - Among 2,296 patients, nonST-segment elevation MI prevalence was 9.8%. In median, 1-h blood samples were collected 65 min after the 0-h blood draw. Overall, 94% of patients were managed without protocol violations, and 98% of patients triaged toward rule-out did not require additional cardiac investigations including high-sensitivity cardiac troponin T measurements at later time points or coronary computed tomography angiography in the ED. Median ED stay was 2 h and 30 min. The ESC 0/1-h algorithm triaged 62% of patients toward rule-out, and 71% of all patients underwent outpatient management. Proportion of patients with 30-day MACE were 0.2% (95% confidence interval: 03% to 0.5%) in the rule-out group and 0.1% (95% confidence interval: 0% to 0.2%) in outpatients. Very low MACE rates were confirmed in multiple subgroups, including early presenters.

 

CONCLUSIONS - These real-world data document the excellent applicability, short time to ED discharge, and low rate of 30-day MACE associated with the routine clinical use of the ESC 0/1-h algorithm for the management of patients presenting with acute chest discomfort to the ED.